The CTUs Principal Investigators from left to right: Dr. Jeffrey Lennox, Dr. Mark Mulligan, and Dr. Carlos del Rio
Dr. del Rio is the leader of the Atlanta Ponce Clinical Research Site. Additionally he is the Hubert Professor and Chair at Rollins School of Public Health, Professor of Medicine at Emory University School of Medicine, and Co-Director of the Emory Center for AIDS Research. His current research focuses on linkage and retention to care for hard-to-reach substance users living with HIV.
Dr. Lennox is Professor of Medicine at Emory University School of Medicine, Associate Dear for Clinical Research, and Vice Chair for Grady Affairs for the Department of Medicine. His leadership in the Emory Healthcare Clinical Trials Unit has ensured successful recruitment and retention of minorities and women into clinical trials. Dr. Lennox is also a member of the Co-Infections and Malignancies Committee of the AIDS Clinical Trials Group (ACTG), serves as an external consultant to the Oral HIV/AIDS Research Alliance Network, and is involved in an international study investigating the in vivo anti-malarial activity of an HIV-1 protease inhibitor.
Dr. Mulligan is Professor of Medicine at the Emory University School of Medicine, Associate Division Director for Clinical and Translational Research in the Division of Infectious Diseases, and Associate Director of the Emory Vaccine Center. The Emory Vaccine Center focuses on vaccine and other prevention technology trials, human translational immunology studies, education, and training vaccine researchers.